Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
PUT
Huntington Ingalls Industries
HII
$11.6B
| $300K | 0.01% |
+1,300
| New | +$306K |
|
1902
CALL
Global Payments
GPN
$25B
| $299K | 0.01% |
3,000
-700
| -19% | -$73K |
|
1903
Norwegian Cruise Line
NCLH
$7.91B
| $299K | 0.01% |
24,437
+8,074
| +49% | +$122K |
|
1904
CALL
Tyson Foods
TSN
$20.4B
| $299K | 0.01% |
4,800
-3,900
| -45% | -$254K |
|
|
FREE
1905
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $299K | 0.01% |
73,365
+9,713
| +15% | +$35.3K |
|
1906
The RealReal
REAL
$1.37B
| $298K | 0.01% |
238,215
| – | – |
|
|
SNV
1907
CALL
DELISTED
Synovus
SNV
| $298K | 0.01% |
+7,900
| New | +$314K |
|
1908
Wave Life Sciences
WVE
$1.01B
| $298K | 0.01% |
42,599
-553
| -1% | -$2.55K |
|
1909
PUT
Dollar Tree
DLTR
$26.3B
| $297K | 0.01% |
+2,100
| New | +$312K |
|
1910
CALL
Molina Healthcare
MOH
$10.4B
| $297K | 0.01% |
900
-1,700
| -65% | -$577K |
|
1911
Uber
UBER
$162B
| $297K | 0.01% |
12,003
+1,903
| +19% | +$52.1K |
|
|
FTCH
1912
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $297K | 0.01% |
62,822
-46,076
| -42% | -$321K |
|
1913
CALL
Lamb Weston
LW
$7.53B
| $295K | 0.01% |
3,300
-4,600
| -58% | -$391K |
|
1914
PUT
Winnebago Industries
WGO
$909M
| $295K | 0.01% |
+5,600
| New | +$319K |
|
1915
Bread Financial
BFH
$4.04B
| $294K | 0.01% |
7,795
-19,343
| -71% | -$698K |
|
|
CTLP
1916
DELISTED
Cantaloupe
CTLP
| $294K | 0.01% |
67,559
-25,769
| -28% | -$91.4K |
|
1917
PUT
Insulet
PODD
$10.1B
| $293K | 0.01% |
+1,000
| New | +$276K |
|
1918
Coherus Oncology
CHRS
$210M
| $292K | 0.01% |
36,828
+13,218
| +56% | +$102K |
|
1919
Starbucks
SBUX
$123B
| $292K | 0.01% |
2,948
| – | – |
|
1920
CALL
Equifax
EFX
$22.9B
| $291K | 0.01% |
1,500
-5,000
| -77% | -$914K |
|
1921
PUT
Wolfspeed
WOLF
$1.29B
| $291K | 0.01% |
+4,200
| New | +$372K |
|
|
VMRK
1922
PUT
Vivmark Residential
VMRK
$25.5B
| $290K | 0.01% |
4,900
-600
| -11% | -$37.5K |
|
|
HOLX
1923
PUT
DELISTED
Hologic
HOLX
| $290K | 0.01% |
3,900
-3,600
| -48% | -$256K |
|
1924
National Health Investors
NHI
$3.59B
| $290K | 0.01% |
+5,547
| New | +$304K |
|
1925
Brixmor Property Group
BRX
$9.08B
| $289K | 0.01% |
+12,751
| New | +$273K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.